Cargando…
Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer deaths worldwide. The high mortality rate in HCC is largely due to the difficulty of early detection. In this study, to improve patient outcomes, serum samples from 345 patients with HCC, 46 patients with chronic hepatitis (CH), 93...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996324/ https://www.ncbi.nlm.nih.gov/pubmed/32025611 http://dx.doi.org/10.1002/hep4.1451 |
_version_ | 1783493503328714752 |
---|---|
author | Yamamoto, Yusuke Kondo, Shunsuke Matsuzaki, Juntaro Esaki, Minoru Okusaka, Takuji Shimada, Kazuaki Murakami, Yoshiki Enomoto, Masaru Tamori, Akihiro Kato, Ken Aoki, Yoshiaki Takizawa, Satoko Sakamoto, Hiromi Niida, Shumpei Takeshita, Fumitaka Ochiya, Takahiro |
author_facet | Yamamoto, Yusuke Kondo, Shunsuke Matsuzaki, Juntaro Esaki, Minoru Okusaka, Takuji Shimada, Kazuaki Murakami, Yoshiki Enomoto, Masaru Tamori, Akihiro Kato, Ken Aoki, Yoshiaki Takizawa, Satoko Sakamoto, Hiromi Niida, Shumpei Takeshita, Fumitaka Ochiya, Takahiro |
author_sort | Yamamoto, Yusuke |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer deaths worldwide. The high mortality rate in HCC is largely due to the difficulty of early detection. In this study, to improve patient outcomes, serum samples from 345 patients with HCC, 46 patients with chronic hepatitis (CH), 93 patients with liver cirrhosis (LC), and 1,033 healthy individuals were analyzed with microRNA (miRNA) microarrays. We investigated the diagnostic potential of circulating miRNAs in serum and developed a detection model of HCC, including early stage. A diagnostic model was constructed based on the expression levels of a combination of miRNAs in a discovery set. We selected 52 miRNAs that had altered expressions according to disease progression status, established the diagnostic model with a combination of eight miRNAs in the discovery set, and tested the model in a validation set. The diagnostic values for discriminating cancer from HCC at‐risk control samples were as follows: area under the curve, 0.99; sensitivity, 97.7%; specificity, 94.7%. With this model, 98% of stage I HCC cases were detected; these results were much better than those observed from conventional methods. Conclusion: Circulating miRNAs could serve as biomarkers for the accurate detection of HCC. Because the diagnostic accuracy was maintained even in stage I, this may represent an accurate detection method even for early stage HCC. |
format | Online Article Text |
id | pubmed-6996324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69963242020-02-05 Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease Yamamoto, Yusuke Kondo, Shunsuke Matsuzaki, Juntaro Esaki, Minoru Okusaka, Takuji Shimada, Kazuaki Murakami, Yoshiki Enomoto, Masaru Tamori, Akihiro Kato, Ken Aoki, Yoshiaki Takizawa, Satoko Sakamoto, Hiromi Niida, Shumpei Takeshita, Fumitaka Ochiya, Takahiro Hepatol Commun Original Articles Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer deaths worldwide. The high mortality rate in HCC is largely due to the difficulty of early detection. In this study, to improve patient outcomes, serum samples from 345 patients with HCC, 46 patients with chronic hepatitis (CH), 93 patients with liver cirrhosis (LC), and 1,033 healthy individuals were analyzed with microRNA (miRNA) microarrays. We investigated the diagnostic potential of circulating miRNAs in serum and developed a detection model of HCC, including early stage. A diagnostic model was constructed based on the expression levels of a combination of miRNAs in a discovery set. We selected 52 miRNAs that had altered expressions according to disease progression status, established the diagnostic model with a combination of eight miRNAs in the discovery set, and tested the model in a validation set. The diagnostic values for discriminating cancer from HCC at‐risk control samples were as follows: area under the curve, 0.99; sensitivity, 97.7%; specificity, 94.7%. With this model, 98% of stage I HCC cases were detected; these results were much better than those observed from conventional methods. Conclusion: Circulating miRNAs could serve as biomarkers for the accurate detection of HCC. Because the diagnostic accuracy was maintained even in stage I, this may represent an accurate detection method even for early stage HCC. John Wiley and Sons Inc. 2019-12-19 /pmc/articles/PMC6996324/ /pubmed/32025611 http://dx.doi.org/10.1002/hep4.1451 Text en © 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Yamamoto, Yusuke Kondo, Shunsuke Matsuzaki, Juntaro Esaki, Minoru Okusaka, Takuji Shimada, Kazuaki Murakami, Yoshiki Enomoto, Masaru Tamori, Akihiro Kato, Ken Aoki, Yoshiaki Takizawa, Satoko Sakamoto, Hiromi Niida, Shumpei Takeshita, Fumitaka Ochiya, Takahiro Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease |
title | Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease |
title_full | Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease |
title_fullStr | Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease |
title_full_unstemmed | Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease |
title_short | Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease |
title_sort | highly sensitive circulating microrna panel for accurate detection of hepatocellular carcinoma in patients with liver disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996324/ https://www.ncbi.nlm.nih.gov/pubmed/32025611 http://dx.doi.org/10.1002/hep4.1451 |
work_keys_str_mv | AT yamamotoyusuke highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT kondoshunsuke highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT matsuzakijuntaro highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT esakiminoru highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT okusakatakuji highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT shimadakazuaki highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT murakamiyoshiki highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT enomotomasaru highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT tamoriakihiro highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT katoken highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT aokiyoshiaki highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT takizawasatoko highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT sakamotohiromi highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT niidashumpei highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT takeshitafumitaka highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease AT ochiyatakahiro highlysensitivecirculatingmicrornapanelforaccuratedetectionofhepatocellularcarcinomainpatientswithliverdisease |